Ostenfeld Sarah, Lindholm Matias Greve, Kjaergaard Jesper, Bro-Jeppesen John, Møller Jacob Eifer, Wanscher Michael, Hassager Christian
Department of Thoracic Anaesthesia, The Heart Centre, Rigshospitalet - Copenhagen University Hospital, Denmark.
Department of Cardiology, The Heart Centre, Rigshospitalet - Copenhagen University Hospital, Denmark.
Resuscitation. 2015 Feb;87:57-62. doi: 10.1016/j.resuscitation.2014.11.010. Epub 2014 Dec 2.
To compare outcome in patients with acute myocardial infarction (MI) and cardiogenic shock (CS) presenting with and without out-of-hospital cardiac arrest (OHCA).
Despite general improvement in outcome after acute MI, CS remains a leading cause of death in acute MI patients with a high 30-day mortality rate. OHCA on top of cardiogenic shock may further increase mortality in these patients resulting in premature withdrawal of supportive therapy, but this is not known.
In a retrospective study from 2008 to 2013, 248 consecutive patients admitted alive to a tertiary centre with the diagnosis of CS and acute MI were enrolled, 118 (48%) presented with OHCA and 130 (52%) without (non-OHCA patients). Mean lactate level at admission was significantly higher in OHCA patients compared with non-OCHA patients (9mmol/l (SD 6) vs. 6mmol/l (SD 4) p<0.0001). Co-morbidities were more prevalent in the non-OHCA group. By univariate analysis age (Hazard ratio (HR)=1.02 [CI 1.00-1.03], p=0.01) and lactate at admission (HR=1.06 [CI 1.03-1.09], p<0.001), but not OHCA (HR=1.1 [CI 0.8-1.4], p=NS) was associated with mortality. In multivariate analysis, only age (HR=1.02 [CI 1.01-1.04], p=0.003) and lactate level at admission (HR=1.06 [1.03-1.09], p<0.001) were independent predictors of mortality. One-week mortality was 63% in the OHCA group and 56% in the non-OHCA group, p=NS.
OHCA is not an independent predictor of mortality in patients with acute MI complicated by cardiogenic shock. This should encourage active intensive treatment of CS patients regardless of OHCA.
比较急性心肌梗死(MI)合并心源性休克(CS)且伴有或不伴有院外心脏骤停(OHCA)患者的预后。
尽管急性心肌梗死后总体预后有所改善,但心源性休克仍是急性心肌梗死患者死亡的主要原因,30天死亡率较高。心源性休克基础上发生院外心脏骤停可能会进一步增加这些患者的死亡率,导致过早停止支持治疗,但目前尚不清楚。
在一项2008年至2013年的回顾性研究中,连续纳入248例入住三级中心且诊断为心源性休克和急性心肌梗死的存活患者,其中118例(48%)伴有院外心脏骤停,130例(52%)不伴有院外心脏骤停(非院外心脏骤停患者)。与非院外心脏骤停患者相比,院外心脏骤停患者入院时的平均乳酸水平显著更高(9mmol/L(标准差6)vs. 6mmol/L(标准差4),p<0.0001)。非院外心脏骤停组的合并症更为普遍。单因素分析显示年龄(风险比(HR)=1.02 [可信区间1.00 - 1.03],p=0.01)和入院时乳酸水平(HR=1.06 [可信区间1.03 - 1.09],p<0.001)与死亡率相关,但院外心脏骤停(HR=1.1 [可信区间0.8 - 1.4],p=无统计学意义)与死亡率无关。多因素分析显示,只有年龄(HR=1.02 [可信区间1.01 - 1.04],p=0.003)和入院时乳酸水平(HR=1.06 [1.03 - 1.09],p<0.001)是死亡率的独立预测因素。院外心脏骤停组的一周死亡率为63%,非院外心脏骤停组为56%,p=无统计学意义。
院外心脏骤停不是急性心肌梗死合并心源性休克患者死亡率的独立预测因素。这应鼓励对心源性休克患者进行积极的强化治疗,无论是否伴有院外心脏骤停。